Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

828 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Screening for Neurocognitive Impairment in HIV-Infected Individuals at First Contact after HIV Diagnosis: The Experience of a Large Clinical Center in Northern Italy.
Focà E, Magro P, Motta D, Compostella S, Casari S, Bonito A, Brianese N, Ferraresi A, Rodari P, Pezzoli MC, Quiros-Roldan E, Castelli F. Focà E, et al. Among authors: castelli f. Int J Mol Sci. 2016 Mar 24;17(4):434. doi: 10.3390/ijms17040434. Int J Mol Sci. 2016. PMID: 27023519 Free PMC article.
Detection of clonal T cell populations with closely related T cell receptor junctional sequences in persons at high risk for human immunodeficiency virus (HIV) infection and in patients acutely infected with HIV.
Bettinardi A, Imberti L, Sottini A, Quiròs-Roldan E, Puoti M, Castelli F, Cadeo GP, Gorla R, Primi D. Bettinardi A, et al. Among authors: castelli f. J Infect Dis. 1997 Feb;175(2):272-82. doi: 10.1093/infdis/175.2.272. J Infect Dis. 1997. PMID: 9203647
Analysis of HIV-1 mutation patterns in patients failing antiretroviral therapy.
Quiros-Roldan E, Signorini S, Castelli F, Torti C, Patroni A, Airoldi M, Carosi G. Quiros-Roldan E, et al. Among authors: castelli f. J Clin Lab Anal. 2001;15(1):43-6. doi: 10.1002/1098-2825(2001)15:1<43::aid-jcla9>3.0.co;2-i. J Clin Lab Anal. 2001. PMID: 11170234 Free PMC article.
Evidence of HIV-2 infection in northern Italy.
Quiros-Roldan E, Castelli F, Pan A, Chiodera S, Casari S, Airoldi M, Carosi G. Quiros-Roldan E, et al. Among authors: castelli f. Infection. 2001 Dec;29(6):362-3. doi: 10.1007/s15010-001-2025-6. Infection. 2001. PMID: 11787844 No abstract available.
Severe hepatotoxicity during combination antiretroviral treatment: incidence, liver histology, and outcome.
Puoti M, Torti C, Ripamonti D, Castelli F, Zaltron S, Zanini B, Spinetti A, Putzolu V, Casari S, Tomasoni L, Quiros-Roldan E, Favret M, Berchich L, Grigolato P, Callea F, Carosi G; HIV-HCV Co-Infection Study Group. Puoti M, et al. Among authors: castelli f. J Acquir Immune Defic Syndr. 2003 Mar 1;32(3):259-67. doi: 10.1097/00126334-200303010-00004. J Acquir Immune Defic Syndr. 2003. PMID: 12626885 Clinical Trial.
Real versus virtual phenotype to guide treatment in heavily pretreated patients: 48-week follow-up of the Genotipo-Fenotipo di Resistenza (GenPheRex) trial.
Mazzotta F, Lo Caputo S, Torti C, Tinelli C, Pierotti P, Castelli F, Lazzarin A, Angarano G, Maserati R, Gianotti N, Ladisa N, Quiros-Roldan E, Rinehart AR, Carosi G; Genotipo-Fenotipo di Resistenza (GenPheRex) Group of the Italian Management Standardizzato di Terapia Antiretrovirale (MASTER) Cohort. Mazzotta F, et al. Among authors: castelli f. J Acquir Immune Defic Syndr. 2003 Mar 1;32(3):268-80. doi: 10.1097/00126334-200303010-00005. J Acquir Immune Defic Syndr. 2003. PMID: 12626886 Clinical Trial.
828 results